TrialBiostatistics (Oxford, England)2023

Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trials.

Ruitao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.